NurExone Biologic Inc. (TSXV:NRX)
0.6400
+0.0300 (4.92%)
At close: Mar 20, 2026
-13.51% (1Y)
| Market Cap | 58.87M +32.3% |
| Revenue (ttm) | n/a |
| Net Income | -9.10M |
| EPS | -0.12 |
| Shares Out | 91.98M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 24,039 |
| Average Volume | 33,311 |
| Open | 0.6100 |
| Previous Close | 0.6100 |
| Day's Range | 0.6100 - 0.6600 |
| 52-Week Range | 0.5700 - 1.1400 |
| Beta | 0.24 |
| RSI | 52.19 |
| Earnings Date | Mar 30, 2026 |